Caplacizumab is a von Willebrand factor (vWF)-directed antibody fragment designed to inhibit the interaction between vWF and platelets.

Every holiday season, millions of Americans hop on a plane to visit friends and family. Most people are anxious about flight delays and ...

Before rotavirus vaccination, some 70,000 children each year would end up in the hospital with severe dehydration due to this ...

Crofelemer has been granted Orphan Drug Designation by the U.S. Food and Drug Administration (FDA) and the European Medicines ...

Kids with broken or sprained limbs don't need oral opioids to treat their pain, according to newly published findings from a ...

While influenza remains the top concern for Maine public health experts, other viruses are also currently circulating, ...

The strain is somewhat resistant to this year’s vaccine, which was created months before the outbreak, medical experts say.

Fresenius Kabi, an Operating Company of Fresenius, and a leading provider of essential medicines and medical technologies, ...

Future Pak becomes exclusive U.S. marketer for Mytesi® and Canalevia®-CA1 Meaningful non-dilutive capital enables Jaguar to ...

It looks like the first strain of flu is running its course—but beware, Influenza B infection typically comes after Influenza ...

Topline data were announced from two phase 3 studies evaluating setrusumab in patients with osteogenesis imperfecta.